Cathie Wood's position in 10x Genomics- Class A is currently worth $170 Million. That's 1.07% of their equity portfolio (25th largest holding). The investor owns 3.63% of the outstanding 10x Genomics- Class A stock. The first 10x Genomics- Class A trade was made in Q2 2020. Since then Cathie Wood bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $522 Million, resulting in a loss of 67%.